|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.3 TWD | +0.87% |
|
+6.15% | -5.67% |
GenMont Biotech Incorporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 318.02 million compared to TWD 368.55 million a year ago. Net income was TWD 32.99 million compared to TWD 56.98 million a year ago.
Basic earnings per share from continuing operations was TWD 0.38 compared to TWD 0.66 a year ago. Diluted earnings per share from continuing operations was TWD 0.38 compared to TWD 0.66 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.67% | 61.91M | |
| +13.21% | 8.15B | |
| -0.47% | 7.27B | |
| +12.30% | 6.65B | |
| -6.99% | 3.72B | |
| -6.49% | 3.67B | |
| -4.78% | 1.31B | |
| +12.61% | 972M | |
| -12.13% | 876M | |
| -38.53% | 866M |
GENMONT BIOTECH INCORPORATION 
